Inventor · disambiguated record
Jack Bevers, Iii
Also filed as: BEVERS III JACK · BEVERS III JACK J
7 granted patents·6 pending applications·22 citations·filing 2015–2024
82Inventor score
Files withGENENTECH INC13
Top patents by PatentIndex Score
13 records- 0192US10723795B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2018·Granted Jul 28, 2020·6 cites·67 claims
- 0286US10093730B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2015·Granted Oct 9, 2018·6 cites·58 claims
- 0385US9975957B2Anti-OX40 antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 22, 2018·5 cites·40 claims
- 0483US11725050B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2020·Granted Aug 15, 2023·1 cites·28 claims
- 0580US10730951B2Anti-OX40 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Aug 4, 2020·2 cites·7 claims
- 0676US11555076B2Anti-MIC antibodies and methods of useGENENTECH INC·Filed 2017·Granted Jan 17, 2023·2 cites·32 claims
- 0766US2024092887A1Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 0866US2021009705A1Anti-ox40 antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 0961US11760797B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2021·Granted Sep 19, 2023·0 cites·27 claims
- 1060US2019062444A1Combination therapy comprising anti-angiogenesis agents and ox40 binding agonistsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1159US2025002575A1Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1255US2017015755A1Combination therapy comprising anti-angiogenesis agents and ox40 binding agonistsGENENTECH INC·Filed 2016·Application pending·0 cites
- 1340US2019211098A1Use of pilra binding agents for treatment of a diseaseGENENTECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jack Bevers, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →